Prothena Corporation plc

PRTA Healthcare Biotechnology

Prothena Corporation plc’s revenue for fiscal 2025 (year ended December 2025) was $9.7 million, down 92.8% from fiscal 2024. In the quarter to June 2026, revenue fell 77.2%, EPS grew 84.6% and free cash flow grew 44.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

8.42 0.01 −0.12%
Market cap
$432.8M
P/E
0.0×
Fwd P/E
188×
Dividend yield
—
F-score
2/9
Altman Z
−0.24
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
9.36 9.01 53.08 44.58
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(20.38) 18.08 (22.05) (12.95)
P/B ratio
1.78 1.67 1.83 1.78
Price to Tangible BV
1.78 1.67 1.83 1.78
EV/Sales
4.08 3.32 21.33 16.51
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(3.70) (2.37) (1.26) (1.03)
EV/FCF
(3.66) (2.36) (1.26) (1.03)
Quick Ratio
24.72 10.13 7.53 6.43
Current Ratio
25.05 10.43 7.72 6.61
Net Debt/EBITDA
14.28 (10.64) 13.22 8.42
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.16 0.14 0.02 0.02
Operating CF/Net income
1.35 0.88 1.08 1.11
Capex/Depreciation
(0.71) 0.00 0.00 (0.01)
Research and Development Expense of Revenue
871.09% 24.72% 69,457.14% 1,198.26%
Selling, General and Administrative Expense of Revenue
1,079.11% 24.79% 60,219.05% 548.16%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
780.00% 13.54% 33,685.71% 298.10%
Graham Net Nets
0.54 0.58 0.52 0.54
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(8.48%) (28.91%) (47.54%) (53.48%)
Free Cash Flow Yield
(11.91%) (15.61%) (31.85%) (35.83%)
Revenue per Share
0.02 0.95 0.00 0.04
Operating CF per Share
(0.48) 0.54 (0.43) (0.75)
Capex per Share
(0.01) 0.00 0.00 0.00
Free Cash Flow per Share
(0.49) 0.54 (0.43) (0.75)
Cash per Share
5.53 6.13 5.71 6.15
Shareholders Equity per Share
5.50 5.82 5.21 5.48
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
5.50 5.82 5.21 5.48
Free Cash Flow
(25.70) 28.88 (23.31) (40.57)
Working Capital
280.36 306.68 274.35 288.54
Capital Expenditures
(0.65) — 0.00 (0.01)
Net Current Asset Value
276.33 301.92 268.86 282.34
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.65 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Payables
7.07 10.16 6.82 10.42
Average Assets
350.82 422.62 436.96 473.94
Average Common Equity
305.61 375.15 383.70 414.68

Fold the line items

Columns are period end dates